Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 71-58-9
- Molecular formula
- C24H34O4
- Molecular weight
- 386.5 g/mol
- Drug class
- Synthetic progestogenester prodrug of medroxyprogesterone
- Mechanism of action
- Activates progesterone receptors, suppressing gonadotropin secretion and ovulation, thickening cervical mucus and producing endometrial changes. The acetate ester is hydrolysed to medroxyprogesterone; depot formulations provide prolonged release and are not interchangeable with the free parent substance by dose.
- Indications / reported uses
- Contraception with the long-acting intramuscular depot formulation
- Treatment of secondary amenorrhoea and prevention of endometrial hyperplasia in selected women receiving oestrogen therapy with oral formulations
- Palliative treatment of selected hormone-responsive cancers in specific high-dose formulations; indication depends on route and formulation
Identification source: PubChem record (CID 6279). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.